Trial ID: | L0489 |
Source ID: | NCT00190580
|
Associated Drug: |
Valsartan
|
Title: |
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
|
Acronym: |
|
Status: |
COMPLETED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
Chronic Kidney Disease|Hypertension
|
Interventions: |
DRUG: valsartan|DRUG: Conventional antihypertensive drugs
|
Outcome Measures: |
Primary: Course of renal and cardiac function, every month for renal function and every year for cardiac function | Secondary: Doubling of serum creatinine concentration, every month|End-stage renal disease, anytime when it occurs.|Myocardial infarction, anytime when it occurs.|Coronary revascularization, anytime when it occurs.|Stroke, anytime when it occurs|Hospitalization for unstable angina, anytime when it occurs.|Hospitalization for heart failure, anytime when it occurs.|Death from cardiovascular causes, anytime when it occurs.
|
Sponsor/Collaborators: |
Sponsor: KVT-Study Group | Collaborators: Tokai University|Yokohama City University|Showa University|Kitasato University|St. Marianna University School of Medicine
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
PHASE4
|
Enrollment: |
312
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2003-02
|
Completion Date: |
2008-04
|
Results First Posted: |
|
Last Update Posted: |
2015-03-31
|
Locations: |
St. Marianna University School of Medicine, Kawasaki, Kanagawa, 216-8511, Japan
|
URL: |
https://clinicaltrials.gov/show/NCT00190580
|